Results 91 to 100 of about 1,788 (174)

Low-sodium oxybate improved symptoms in adults with idiopathic hypersomnia: A Plain Language Summary of Publication

Future Neurology
Yves Dauvilliers, Anne Marie Morse, Patricia Chandler, Amy Desmarais, Richard K. Bogan   +4 more
openaire   +1 more source

Can Sodium Oxybate Mitigate the Symptoms of Schizophrenia? [PDF]

Curr Neuropharmacol
Mamelak M.
europepmc   +1 more source

Sodium Oxybate as a Potential New Treatment for Catatonia in Patients With Depression, Bipolar Disorder, or a Psychotic Disorder: Protocol for a Randomized Controlled Trial. [PDF]

JMIR Res Protoc
Bot L, van Mill JG, Smarius LJCA, Hoogendoorn AW, Storosum BWC, Vinkers CH, Jacobs GE, Lammers GJ, Heller HM, Colen-de Koning JCA, van der Vlugt JJB, Oudijn MS, van Noorden MS, Bet PM, Fronczek R, van der Heijden HS, Lange SMM, van der Werf YD, van Exel ER.   +18 more
europepmc   +1 more source

Pharmacologic treatment of fibromyalgia: an update. [PDF]

Front Pharmacol
Li Y, Li Y, Wu S, Long M, Chen X, Wang Y, Zhao J, He B, Chang C, Jiao J.   +9 more
europepmc   +1 more source

Prescription Drugs Subject to a Risk Evaluation and Mitigation Strategy: Patient Perspectives on Risk Communication and the Value of Educational Materials. [PDF]

Drug Saf
Chimonas S, Cosenza C, Kesselheim AS, Toyserkani GA, Oswell KH, LaCivita C, Dal Pan GJ, Sarpatwari A.   +7 more
europepmc   +1 more source

Sodium oxybate for the treatment of alcohol dependence [PDF]

, 2023
Guiraud, J.
core  

Comparative efficacy of new wake-promoting agents for narcolepsy-a network meta-analysis. [PDF]

BMC Neurol
Yan Z, Li J, Yu Y, Qiu S, Wang B, Tang J.   +5 more
europepmc   +1 more source

Sodium Oxybate: Practical Considerations and Patient Perspectives. [PDF]

CNS Drugs
Lavender M, Martin C, Anderson D.
europepmc   +1 more source

Therapeutic Use of γ-Hydroxybutyrate: History and Clinical Utility of Oxybates and Considerations of Once- and Twice-Nightly Dosing in Narcolepsy. [PDF]

CNS Drugs
Roth T.
europepmc   +1 more source

Sleep disorders in Parkinson's disease: evaluating pharmacological treatments through systematic review and meta-analysis. [PDF]

BMC Neurol
Li J, Zhou R, Deng J, Zhou H, Hu J, Wang X.   +5 more
europepmc   +1 more source